2-methoxyestradiol has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adlercreutz, H; Fotsis, T; Montesano, R; Nawroth, PP; Pepper, MS; Schweigerer, L; Zhang, Y | 1 |
1 other study(ies) available for 2-methoxyestradiol and B16 Melanoma
Article | Year |
---|---|
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth.
Topics: 2-Methoxyestradiol; 3T3 Cells; Administration, Oral; Animals; Antineoplastic Agents; Cattle; Cells, Cultured; Drug Screening Assays, Antitumor; Endothelium, Vascular; Estradiol; Fibroblast Growth Factor 2; Humans; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Sarcoma, Experimental; Tumor Cells, Cultured | 1994 |